Achmea Investment Management B.V. Buys Shares of 43,686 UiPath Inc. (NYSE:PATH)

Achmea Investment Management B.V. purchased a new position in UiPath Inc. (NYSE:PATH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 43,686 shares of the healthcare company’s stock, valued at approximately $554,000.

Other large investors also recently modified their holdings of the company. Russell Investments Group Ltd. grew its position in UiPath by 23.7% during the fourth quarter. Russell Investments Group Ltd. now owns 38,584 shares of the healthcare company’s stock valued at $958,000 after buying an additional 7,382 shares during the period. Victory Capital Management Inc. raised its holdings in UiPath by 64.3% in the 4th quarter. Victory Capital Management Inc. now owns 74,351 shares of the healthcare company’s stock worth $1,847,000 after purchasing an additional 29,111 shares during the period. Jump Financial LLC purchased a new position in UiPath during the fourth quarter valued at $996,000. Dimensional Fund Advisors LP grew its holdings in UiPath by 11.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,232,060 shares of the healthcare company’s stock valued at $55,454,000 after purchasing an additional 232,700 shares during the period. Finally, Avantax Advisory Services Inc. increased its position in UiPath by 7.1% in the fourth quarter. Avantax Advisory Services Inc. now owns 12,293 shares of the healthcare company’s stock worth $305,000 after buying an additional 811 shares in the last quarter. Institutional investors own 62.50% of the company’s stock.

UiPath Stock Up 4.1 %

PATH stock opened at $12.51 on Friday. The firm’s fifty day simple moving average is $12.12 and its two-hundred day simple moving average is $16.27. The stock has a market capitalization of $7.17 billion, a price-to-earnings ratio of -78.19 and a beta of 0.87. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87.

UiPath (NYSE:PATH) last posted its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The company had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. During the same period in the prior year, the company posted ($0.09) EPS. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. As a group, equities research analysts expect that UiPath Inc. will post -0.23 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on PATH shares. JPMorgan Chase & Co. dropped their price target on shares of UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Truist Financial reiterated a “hold” rating and issued a $14.00 price target (down previously from $32.00) on shares of UiPath in a research note on Thursday, May 30th. KeyCorp restated a “sector weight” rating on shares of UiPath in a research report on Thursday, May 30th. Macquarie cut UiPath from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $29.00 to $12.00 in a research report on Monday, June 3rd. Finally, TD Cowen lowered their price target on UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, September 6th. Sixteen research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, UiPath currently has an average rating of “Hold” and a consensus price target of $17.71.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.